odinated contrast medium used in diagnostic and therapeutic cardiac catheterization can cause renal damage, which ranges from a transient elevation of the serum creatinine (SCr) concentration to permanent renal failure necessitating dialysis. 1,2 Recent studies have shown that contrast-induced nephropathy (CIN) is the third leading cause of all hospital-acquired renal insufficiency, accounting for 10%, 3 and is associated with increased long-term mortality. 4 CIN is defined as an increase in SCr ≥0.5 mg/dl or ≥25% of the baseline level reaching a peak between 2 and 5 days after administration of the contrast medium. [5] [6] [7] The incidence of CIN in previous reports varies among studies because of differences in the definition of CIN, background risk, type and dose of contrast medium, and the frequency of other potential causes of CIN. 6 The most important risk factor for CIN is preexisting renal insufficiency. 8, 9 Older age, female gender, anemia, high-dose usage of contrast medium, heart failure, diabetes mellitus and peripheral vascular disease (PVD) are also reported as risk factors that increase the likelihood of CIN. [9] [10] [11] [12] It is still uncertain to what extent these factors independently worsen renal function.
for women, 18 and a baseline SCr ≥1.2 mg/dl. [19] [20] [21] Patients with New York Heart Association class ≥II were regarded as suffering from congestive heart failure (CHF). PVDs included arterial sclerosis obliterans, and renal and carotid artery stenosis. The volume of administered contrast medium is linked to the development of CIN, although the volume of the medium to induce CIN varies and was not definitive in the previous studies. 8 Some studies report that the tolerated dose of contrast medium depends on kidney function, 6 but we opted for the simple definition of high volume of contrast medium ≥200 ml for practical and easier application. 8, 12 Statistical Analysis Continuous variables of each group are presented as mean ± standard deviation and the categorical variables are expressed as number and percentage. The potential risk factors for CIN examined in the present study were elderly, female gender, underweight, anemia, preexisting renal insufficiency, high-dose contrast medium, diabetes mellitus (DM), CHF, and PVD. 9, 10 Age was dichotomized to elderly or not (≥70 years old vs <70 years), BMI dichotomized to underweight or not (BMI <18.5 vs ≥18.5), Hb concentration dichotomized to anemia or not (Hb concentration <13 g/dl vs ≥13 g/dl for men and <12 g/dl vs ≥12 g/dl for women), renal function dichotomized to insufficiency or not (baseline SCr ≥1.2 mg/dl vs <1.2 mg/dl), and the volume of contrast medium dichotomized to high or not (≥200 ml vs <200 ml). The univariate relationships between CIN and these variables were evaluated using the chi-square test, followed by multiple logistic regression models with all potential risk factors with a P value <0.20 by univariate analysis. The results of analysis are shown as odds ratio (OR) given with 95% confidence interval (CI) and P values. Results were considered as significant with a P value of <0.05. We used JMP 8 (SAS Institute Inc, Cary, NC) for all analyses.
Results

Baseline Clinical Characteristics
The baseline clinical characteristics of the 1,157 patients in the present study are listed in Table 1 . Mean age, percentage of elderly, and female gender were 68.4±11.5 years old, 54.1%, and 28.4%, respectively. The mean BMI and the percentage of underweight, and the mean Hb concentration and the percentage of anemia were 23.3±3.7, 9.1%, 12.7± 2.1 g/dl, and 44.3%, respectively. The prevalence of preexisting renal insufficiency, DM, CHF, and PVD were 22.0%, 36.1%, 18.9% and 22.6%, respectively. Percutaneous coronary intervention was performed in a total of 48.6% of patients.
Procedural and Renal Outcomes
The mean dose of contrast agent was 185.5±103.5 ml ( Table 2) . The percentage of patients administered with a high volume of the contrast media was 36.8%. The mean baseline SCr and the absolute change in SCr after administration of the contrast media were 0.97±0.39 mg/dl and 0.08± 0.22 mg/dl. In our study population, an absolute increase in SCr ≥0.5 mg/dl occurred in 46 patients (4.0%) and a relative 25% increase in SCr was observed in 160 patients (13.8%). The incidence of either an absolute increase or a relative increase was 13.9% (161/1,157).
Contrast Volume and the Incidence of CIN
Those patients who received the highest quartile of contrast volume were 3-fold more likely to develop CIN defined as an absolute increase in SCr ≥0.5 mg/dl (8.3% vs 2.6%, P=0.002) (Figure 1 ), 2-fold more likely to develop CIN defined as a relative ≥25% increase (22.4% vs 9.7%, P< 0.0001) (Figure 2 ) and either the absolute increase or the relative increase (22.4% vs 10.1%, P<0.0001) compared with those with the lowest quartile of contrast volume.
Univariate and Multivariate Analyses
Univariate factors correlated with the absolute increase in SCr ≥0.5 mg/dl after cardiac catheterization included elderly, anemia, preexisting renal insufficiency, the use of a high volume of contrast media, and PVD ( Table 3 ). In contrast, univariate correlates of the relative 25% increase in SCr included female gender, underweight, anemia, and the use of a high volume of contrast media ( Table 4) , and univariate correlates of either an absolute increase or relative increase were female gender (P=0.002), underweight (P= 0.001), anemia (P=0.02), and the use of a high volume of contrast media (P<0.0001).
Multivariate analysis revealed that the use of high-volume contrast was independently associated with both the abso- Continuous variables are mean ± standard deviation and the categorical variables are expressed as number and percentage. CIN, contrast-induced nephropathy. Other abbreviation see in Table 1 . Abbreviations see in Tables 1,2 . Abbreviations see in Tables 1,2 . lute increase in SCr ≥0.5 mg/dl (OR 3.81; 95%CI 2.01-7.49; P<0.0001) ( 
Discussion
The major findings of this study are as follows. (1) The incidence of an absolute increase in SCr ≥0.5 mg/dl, relative ≥25% increase in SCr, and either an absolute or relative increase after cardiac catheterization was 4.0%, 13.8%, and 13.9%, respectively. (2) After adjusting for the risk factors for CIN previously reported, [8] [9] [10] preexisting renal insufficiency and the use of high-volume contrast were independent risk factors for an absolute increase in SCr ≥0.5 mg/dl after cardiac catheterization, and female gender, underweight, and the use of high-volume contrast were independent risk factors for a relative ≥25% increase in SCr and either an absolute increase or relative increase.
Incidence of CIN After Cardiac Catheterization in Japanese Patients
The rate of absolute increase in SCr ≥0.5 mg/dl, relative ≥25% increase, and either an absolute or relative increase in SCr after cardiac catheterization was 4.0%, 13.8%, and 13.9%, respectively, in our study group. Although the incidence of CIN after cardiac catheterization in previous reports varied, 1 study reported that the incidence of an absolute increase in SCr ≥0.5 mg/dl was 3.3% 4 and another reported that the relative ≥25% increase in SCr was 14.5%. 1 In other studies with small samples of Japanese patients, the incidences of CIN defined as either an absolute increase of ≥0.5 mg/dl or a relative increase of ≥25% in SCr were 20.3% (12/59) 22 and 20.7% (18/87). 23 The incidence of CIN in those studies was relatively higher than in ours using the same definition, although baseline renal function was somewhat better in the patients in our study. Kawashima et al reported that 11% of 332 Japanese patients with mild renal dysfunction (1.3≤ SCr <2.0 mg/dl) developed CIN defined as either an absolute increase of ≥0.5 mg/dl or a relative increase of ≥25% in SCr within 7 days of the procedure. 12
Risk Factors for CIN After Cardiac Catheterization in Japanese Patients
The results of multivariate analysis in the present study revealed that preexisting renal insufficiency and the use of high-volume contrast were independently associated with an absolute increase in SCr ≥0.5 mg/dl after cardiac catheterization. On the other hand, female gender, underweight, and the use of high-volume contrast were independent risk factors for a relative ≥25% increase and either an absolute increase or relative increase in SCr. Risk factors for CIN varied among previous studies because of differences in the definition of CIN, background risk, type and dose of contrast medium, and the frequency of other potential causes of CIN. 6 Therefore, preexisting renal insufficiency, the use of high-volume contrast, female gender, and underweight are all considered as risk factors for CIN in Japanese patients. Of these, women have a higher prevalence of DM, hypertension, and being elderly. 24 Because the association of high BMI with better survival in chronic kidney disease is considered a "risk factor paradox" or "reverse epidemiology", 25, 26 we examined and found that underweight was an independent risk factor for CIN. In contrast to previous reports, DM, anemia, and CHF did not correlate with CIN in the present study. Although PVD (OR 1.93; 95%CI 0.995-3.69; P=0.052) and DM (OR 1.42; 95%CI 0.73-2.74; P=0.3) had a tendency to increase CIN as an absolute increase in SCr ≥0.5 mg/dl, and anemia (OR 1.40; 95%CI 0.96-2.04; P=0.08) had a tendency to increase CIN as a relative ≥25% increase in SCr, our sample size might be too small to detect the significance of these factors. Because volume depletion is considered to be a risk factor for CIN, 7, 27 and intravenous hydration has been shown to reduce the frequency of CIN, 28 CHF as a consequence of volume excess might not be associated with CIN in our study population. Although the differences in the incidence of CIN among individual contrast media have been previously reported, 29 we could not find any significant difference between iomeprol and iopamidol.
Study Limitations
First, our study included a relatively small population, admitted to a single center. Therefore, the total number of CIN cases defined as an absolute increase in SCr ≥0.5 mg/dl, a relative ≥25% increase, and either an absolute increase or relative increase in SCr that we observed was only 46, 160, and 161, respectively. Although our sample size was the largest among the previous studies, the number of patients might not be enough to precisely represent Japanese patients. Because the statistical power was insufficient, several risk factors that were shown significant in the previous reports were not statistically associated with CIN in the present study. Second, we included patients in a retrospective fashion. Therefore, all patients underwent cardiac catheterization according to the doctors' judgment. Some patients did not undergo cardiac catheterization because of preexisting conditions, which undoubtedly resulted in selection bias.
Third, data on hydration status and potential nephrotoxic drugs, such as NSAIDs, were unavailable because this study was retrospective.
Fourth, our study was conducted in a single center in Japan and all enrolled patients were Japanese, thus, the muscular volume or other factors associated with renal function may differ from other populations. Therefore, the generalization of our findings is uncertain. These issues should be attested in future prospective studies.
Clinical Implications
We have investigated the incidence of CIN after cardiac catheterization in Japanese patients. CIN is not only the third leading cause of hospital-acquired renal insufficiency but is also associated with increased long-term mortality. Because percutaneous coronary intervention is reported to have no effects on reducing major cardiovascular events, 30 we should endeavor to avoid the development of CIN after cardiac catheterization.
We should also pay careful attention to patients who have risk factors, such as preexisting renal insufficiency, the use of high-volume contrast, female gender, and underweight.
Conclusions
In our study population, the incidence of CIN defined as an absolute increase in SCr ≥0.5 mg/dl, a relative ≥25% increase, and either an absolute increase or relative increase in SCr after cardiac catheterization in Japanese patients was 4.0%, 13.8%, and 13.9%, respectively. After adjustment for risk factors for CIN previously reported, preexisting renal insufficiency, the use of high-volume contrast, female gender, and underweight were shown to be independent risk factors for CIN. To validate our results, a large multicenter study is needed.
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